These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10408989)

  • 1. Use of antacids in a general population: the impact of health-related variables, lifestyle and sociodemographic characteristics.
    Furu K; Straume B
    J Clin Epidemiol; 1999 Jun; 52(6):509-16. PubMed ID: 10408989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-ulcer dyspepsia and peptic ulcer: the distribution in a population and their relation to risk factors.
    Bernersen B; Johnsen R; Straume B
    Gut; 1996 Jun; 38(6):822-5. PubMed ID: 8984017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effectiveness of ranitidine in non-ulcer dyspepsia (functional dyspepsia) in comparison with an antacid].
    Hotz J; Plein K; Bunke R
    Med Klin (Munich); 1994 Feb; 89(2):73-80, 107. PubMed ID: 8164599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptic ulcer and non-ulcer dyspepsia--a disease and a disorder.
    Johnsen R; Straume B; Førde OH
    Scand J Prim Health Care; 1988 Nov; 6(4):239-43. PubMed ID: 3266022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self medication and health habits in the management of upper gastrointestinal symptoms.
    Sihvo S; Hemminki E
    Patient Educ Couns; 1999 May; 37(1):55-63. PubMed ID: 10640120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-medication of upper gastrointestinal symptoms with hydrotalcite: a noninterventional community pharmacy study on drug usage and patient satisfaction.
    Häcker F; Morck H
    Int J Clin Pharmacol Ther; 2012 Feb; 50(2):87-99. PubMed ID: 22257575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heartburn: community perceptions.
    Bolin TD; Korman MG; Hansky J; Stanton R
    J Gastroenterol Hepatol; 2000 Jan; 15(1):35-9. PubMed ID: 10719745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing of antacids and ulcer-healing drugs in primary care in the north of England.
    Roberts SJ; Bateman DN
    Aliment Pharmacol Ther; 1995 Apr; 9(2):137-43. PubMed ID: 7605853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why do apparently healthy people use antacid tablets?
    Graham DY; Smith JL; Patterson DJ
    Am J Gastroenterol; 1983 May; 78(5):257-60. PubMed ID: 6846300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antacid (A02A) and antiulcer (A02B) drug prescription patterns: predicting factors, dosage and treatment duration.
    Morales Suárez-Varela MM; Pérez-Benajas MA; Girbes Pelechano VJ; Llopis-González A
    Eur J Epidemiol; 1998 Jun; 14(4):363-72. PubMed ID: 9690755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antacids, alginates and proton pump inhibitors: a survey of the general Danish population using an internet panel.
    Lødrup A; Reimer C; Bytzer P
    Scand J Gastroenterol; 2014 Sep; 49(9):1044-50. PubMed ID: 24874283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heartburn and dyspeptic symptoms. Almost all sour types respond to antacids].
    MMW Fortschr Med; 2001 May; 143(20):62-3. PubMed ID: 11400617
    [No Abstract]   [Full Text] [Related]  

  • 13. The emergency department treatment of dyspepsia with antacids and oral lidocaine.
    Welling LR; Watson WA
    Ann Emerg Med; 1990 Jul; 19(7):785-8. PubMed ID: 2202240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-medication of dyspepsia: how appropriate is it?
    Sihvo S; Hemminki E
    Scand J Gastroenterol; 1997 Sep; 32(9):855-61. PubMed ID: 9299660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of upper gastrointestinal symptoms in Brazil (EpiGastro): a population-based study according to sex and age group.
    do Rosário Dias de Oliveira Latorre M; Medeiros da Silva A; Chinzon D; Eisig JN; Dias-Bastos TR
    World J Gastroenterol; 2014 Dec; 20(46):17388-98. PubMed ID: 25516650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dyspeptic symptoms in primary care. An observational study in general practice.
    Maconi G; Tosetti C; Stanghellini V; Bianchi Porro G; Corinaldesi R
    Eur J Gastroenterol Hepatol; 2002 Sep; 14(9):985-90. PubMed ID: 12352218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifestyle factors and efficacy of lifestyle interventions in gastroesophageal reflux disease patients with functional dyspepsia: primary care perspectives from the LEGEND study.
    Haruma K; Kinoshita Y; Sakamoto S; Sanada K; Hiroi S; Miwa H
    Intern Med; 2015; 54(7):695-701. PubMed ID: 25832928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisapride compared with ranitidine in the treatment of functional dyspepsia.
    Carvalhinhos A; Fidalgo P; Freire A; Matos L
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):411-7. PubMed ID: 7614103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Users and utilization patterns of over-the-counter acid inhibitors and antacids in The Netherlands.
    Van Vliet EP; Kuipers EJ; Steyerberg EW; Siersema PD
    Scand J Gastroenterol; 2008; 43(6):662-8. PubMed ID: 18569982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lifestyle of patients with self-reported food hypersensitivity differ little from controls.
    Lind R; Olafsson S; Hjelland I; Berstad A; Lied GA
    Gastroenterol Nurs; 2008; 31(6):401-10. PubMed ID: 19077834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.